Novartis

Novartis Settles U.S. Bribery Charges
Risk & Compliance

Novartis Settles U.S. Bribery Charges

The pharma giant will pay more than $346 million to settle charges that it bribed doctors to prescribe their drugs.
By Lauren Muskett | June 26, 2020
Read More
Novartis to Buy AveXis in $8B Gene Therapy Bet
Strategy

Novartis to Buy AveXis in $8B Gene Therapy Bet

The deal gives the Swiss drugmaker a neurological disease treatment that may have "a multi-billion dollar peak sales potential."
By Matthew Heller | April 9, 2018
Read More
GSK Buys Novartis out of Joint Venture for $13B
Strategy

GSK Buys Novartis out of Joint Venture for $13B

The acquisition of Novartis' stake will give GSK full control over the revenues from such products as Sensodyne toothpaste and the Excedrin pain reliever.
By Matthew Heller | March 27, 2018
Read More
Specialty Drug Costs to Soar Again in 2018
Human Capital & Careers

Specialty Drug Costs to Soar Again in 2018

The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
By David McCann | September 22, 2017
Read More
Novartis Settles Kickback Charges for $370M
Risk & Compliance

Novartis Settles Kickback Charges for $370M

The Swiss drug maker allegedly turned specialty pharmacies into a "biased sales force" for its medications.
By Matthew Heller | November 20, 2015
Read More
CFO Snapshot: Sweating in Front of the Board
Profiles

CFO Snapshot: Sweating in Front of the Board

Meryl Zausner, the U.S. finance chief of Novartis, shares her thoughts on the CFO role and the path she took to get there.
By Kate O'Sullivan | July 27, 2012
Read More
Risk Takers, Career Makers
People

Risk Takers, Career Makers

How are women making it to the top in finance? Sometimes by making unconventional, even risky, career moves.
By Alix Stuart | May 15, 2012
Read More